Development of Technologies to Facilitate the Use of and Response to Vaccines

Emergent Product Development Gaithersbur, Gaithersburg MD

Investigators

Abstract

This contract supports the advanced development of candidate products, comprised of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases. Such technologies are intended to simplify and expedite delivery of vaccine to large numbers of patients.